Heart Failure With Preserved Ejection Fraction
241
62
76
75
Key Insights
Highlights
Success Rate
82% trial completion
Published Results
27 trials with published results (11%)
Research Maturity
75 completed trials (31% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
7.1%
17 terminated out of 241 trials
81.5%
-5.0% vs benchmark
15%
37 trials in Phase 3/4
36%
27 of 75 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 75 completed trials
Clinical Trials (241)
Assessment of CCM in HF With Higher Ejection Fraction
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Metformin for Older Patients With Heart Failure With Preserved Ejection Fraction
Incretin Therapies in Obesity-related HFpEF
Pilot Study Lp299v Supplementation in Chronic Heart Failure
Manganese-enhanced Magnetic Resonance Imaging (MEMRI) in Heart Failure With Preserved Ejection Fraction
A Study of 68Ga-Fibroblast Activation Protein Inhibitor (FAPI) Positron Emission Tomography in Heart Failure
Fast Induced Remodeling in Heart Failure With Preserved Ejection Fraction
Quality of Sleep of Patients With Predominant Central Sleep Apnea Syndrome(SAS) Whose EF > 45% Treated by ASV
Administration of the SGLT-2 Inhibitor Dapagliflozin in the Patients With Amyloid Cardiomyopathy
Novel Approaches for Improving Vascular Function in Veterans With HFpEF
Exercise Cardiovascular Magnetic Resonance In Heart Failure With Preserved Ejection Fraction
Physical Activity, Cardiac and Skeletal Muscle Energetics in Healthy Subjects and HFpEF Patients
SGLT2i and KNO3 in HFpEF - The SAK HFpEF Trial
CMR T1 Mapping for Diagnosis of Cardiac Amyloidosis
Effect of Dapagliflozin on Metabolomics and Cardiac Mechanics in Chronic Kidney Disease
HeartShare: Combining Omics, Deep Phenotyping, and Electronic Health Records for Heart Failure Subtypes and Treatment Targets
Myocardial Mechanisms in Heart Failure With Preserved Ejection Fraction
Effectiveness of a Cardiac Rehabilitation Program in Elderly Patients With Heart Failure.
A Study of TX000045 in Patients With Pulmonary Hypertension Secondary to Heart Failure With Preserved Ejection Fraction (the APEX Study)